Allspring Global Investments
MCRB icon

Allspring Global Investments’s Seres Therapeutics MCRB Stock Holding History

Allspring Global Investments’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31
Closed -$578 – 2142
2024
Q3 		$578 Hold
31
– – ﹤0.01% 2368
2024
Q2 		$442 Buy
+31
New +$517 ﹤0.01% 2317
2023
Q3 		– Hold
0
– -$4 – 2852
2023
Q2 		– Sell
-99
Closed -$10.8K – 2685
2023
Q1 		$11.2K Sell
99
-243
-71% -$26.3K ﹤0.01% 2584
2022
Q4 		$38.3K Sell
342
-8
-2% -$1.07K ﹤0.01% 2416
2022
Q3 		$44K Hold
350
– – ﹤0.01% 2401
2022
Q2 		$23K Sell
350
-17
-5% -$1.47K ﹤0.01% 2454
2022
Q1 		$52K Buy
+367
New +$56.4K ﹤0.01% 2844

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's MCRB Position: Q4 2024 in Review

Allspring Global Investments sold out of Seres Therapeutics (MCRB) in Q4 2024, closing a stake of 31 shares — an estimated $578 sold.

Allspring Global Investments first reported a position in MCRB in Q1 2022 and held it in 7 quarters. The position peaked at $52K in Q1 2022. 69 funds tracked by Wall St. Rank hold MCRB as of Q4 2024.

  • Allspring Global Investments reported no remaining Seres Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 31 Seres Therapeutics shares in Q4 2024, an estimated $578.
  • Allspring Global Investments first reported a position in Seres Therapeutics in Q1 2022 and held it in 7 quarters.
  • Allspring Global Investments's Seres Therapeutics position peaked at $52K in Q1 2022.
  • 69 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.